InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,035.69
(
-1.57%
)
US TECH 100
16,857.20
(
-0.74%
)
Dow Jones
37,815.92
(
-1.49%
)
Brent Oil
85.19
(
-0.83%
)
Bitcoin
57,550.54
(
-5.03%
)
Post# of 183
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Report Keyboard Shortcuts
Prev Next

mlkrborn

Send PM Follow Ignore
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

mlkrborn

Re: surf1944 post# 182

Monday, 08/24/2009 5:31:13 PM

Monday, August 24, 2009 5:31:13 PM

Post# of 183
Ligand Pharmaceuticals Inc. (LGND, $2.54, -$0.22, -7.97%) announced plans to buy cash-strapped drug developer Neurogen Corp. (NRGN, $0.20, +$0.00, -0.15%) for $11 million in stock plus the potential for millions more in cash, giving Ligand access to a partnership with Merck & Co. (MRK, $32.50, -$0.06, -0.18%).
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Report Keyboard Shortcuts
Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM

Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!